Organigram Global (OGI) EBITDA: 2018-2021
Historic EBITDA for Organigram Global (OGI) over the last 3 years, with May 2021 value amounting to -$4.2 million.
- Organigram Global's EBITDA rose 95.33% to -$4.2 million in Q2 2021 from the same period last year, while for May 2021 it was $261.4 million, marking a year-over-year increase of 406.68%. This contributed to the annual value of -$10.9 million for FY2025, which is 57.15% up from last year.
- Organigram Global's EBITDA amounted to -$4.2 million in Q2 2021, which was down 106.31% from $66.4 million recorded in Q1 2021.
- Organigram Global's 5-year EBITDA high stood at $233.5 million for Q3 2020, and its period low was -$89.6 million during Q2 2020.
- Over the past 3 years, Organigram Global's median EBITDA value was $3.6 million (recorded in 2019), while the average stood at $19.3 million.
- Examining YoY changes over the last 5 years, Organigram Global's EBITDA showed a top increase of 7,052.74% in 2020 and a maximum decrease of 3,654.46% in 2020.
- Over the past 4 years, Organigram Global's EBITDA (Quarterly) stood at $29.5 million in 2018, then slumped by 96.73% to $964,000 in 2019, then slumped by 3,654.46% to -$34.3 million in 2020, then surged by 95.33% to -$4.2 million in 2021.
- Its last three reported values are -$4.2 million in Q2 2021, $66.4 million for Q1 2021, and -$34.3 million during Q4 2020.